Auto-Injector Market is anticipated
to grow at a significant CAGR during the forecast period. Auto injectors are
alternative to manual syringe injections for subcutaneous administration of
drugs. The devices allow the patient to self-inject for diagnosis. Patients
with a chronic history of autoimmune disorders and multiple scelerosis are
known to have using auto injectors. Technically, auto injector devices are auto
injector pens having a push switch at the top with a closure.
Auto injector market is driven by rise in prevalence of
targeted therapies such as multiple scelerosis, rheumatoid arthritis and higher
incidence of anaphylaxis. In addition, availability of various auto-injector
devices for better route of drug administration is supplementing the market
growth. High risks associated with conventional syringes coupled with
discontinuation of drugs also propels the market growth. Patient compliance,
demand for biologics, rise in number of diabetic patients and growth in cancer
cases are more likely to enlarge the market demand. However, regulatory
approvals, injuries, infections and mortality rate hinder the market growth
during the forecast period.
Request Sample Copy
of this Market Research @ https://www.millioninsights.com/industry-reports/auto-injector-market/request-sample
Product segmentation for auto injector market comprises
fillable and prefilled auto injectors. By technology, the market entails
automated and manual auto injectors. By design, the market is bifurcated into
standardized and customized. Usability segment for auto-injector industry
comprises reusable and disposable auto injectors.
Geographical segmentation for the market comprises North
America, South America, Europe, Asia-Pacific, Middle East and Africa. North
America dominates the global market owing to presence of medical
infrastructure, FDA approvals and rise in prevalence of anaphylaxis. Increasing
prevalence of autoimmune and chronic disease in US are triggering the regional
market growth.
Asia-Pacific regions are rising at a higher CAGR due to
rising incidences of autoimmune disorders, availability of medical
infrastructure and significance of technological developments in the region.
The key players profiled in auto-injector market report are Amgen, Abbvie,
Biogen, Eli Lilly, Merck, J&J, Novartis, Bayer, Ypsomed, Becton, Dickinson
& Company, Owen Mumford and Haselmeier.
Browse Complete
Report with TOC @ https://www.millioninsights.com/industry-reports/auto-injector-market
Market Segment:
Report contents
include
• Analysis of the auto-injector market including revenues,
future growth, market outlook
• Historical data and forecast
• Regional analysis including growth estimates
• Analyzes the end user markets including growth estimates.
• Profiles on auto-injector including products,
sales/revenues, and market position
• Market structure, market drivers and restraints.
Key regions
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South America
Key Vendors
• request free sample to get a complete list of companies
For More Information,
Visit Our Blog @ www.digitalmarket360.wordpress.com
